Cargando…
A Replicating Single-Cycle Adenovirus Vaccine Effective against Clostridium difficile
Clostridium difficile causes nearly 500,000 infections and nearly 30,000 deaths each year in the U.S., which is estimated to cost $4.8 billion. C. difficile infection (CDI) arises from bacteria colonizing the large intestine and releasing two toxins, toxin A (TcdA) and toxin B (TcdB). Generating hum...
Autores principales: | Matchett, William E., Anguiano-Zarate, Stephanie, Malewana, Goda Baddage Rakitha, Mudrick, Haley, Weldy, Melissa, Evert, Clayton, Khoruts, Alexander, Sadowsky, Michael, Barry, Michael A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7564163/ https://www.ncbi.nlm.nih.gov/pubmed/32842679 http://dx.doi.org/10.3390/vaccines8030470 |
Ejemplares similares
-
Genetic Adjuvants in Replicating Single-Cycle Adenovirus Vectors Amplify Systemic and Mucosal Immune Responses against HIV-1 Envelope
por: Matchett, William E., et al.
Publicado: (2020) -
Convenient Protocol for Production and Purification of Clostridioides difficile Spores for Germination Studies
por: Weldy, Melissa, et al.
Publicado: (2020) -
Comparison of systemic and mucosal immunization with replicating Single cycle Adenoviruses
por: Matchett, William E, et al.
Publicado: (2018) -
Replicating Single-Cycle Adenovirus Vectors Generate Amplified Influenza Vaccine Responses
por: Crosby, Catherine M., et al.
Publicado: (2017) -
Complete Microbiota Engraftment Is Not Essential for Recovery from Recurrent Clostridium difficile Infection following Fecal Microbiota Transplantation
por: Staley, Christopher, et al.
Publicado: (2016)